EUVIMEDEUVIMED entdecken
Beobachtungsstudie

The relation of polymer structure of stent used in patients with acute coronary syndrome revascularized by stent implantation with long‐term cardiovascular events

Barış Yaylak iD, Fuat Polat iD, Tolga Onuk iD, Şükrü Akyüz iD, Ali Nazmi Çalık iD, Mustafa Çetin iD, Semih Eren iD, Feyza Mollaalioğlu iD, Zeynep Kolak iD, Furkan Durak iD, Şennur Ünal Dayı iD

Catheterization and Cardiovascular Interventions · 2023

DOI: 10.1002/ccd.30881 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2023. Verfasst von Barış Yaylak und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Educatıon Research Hospıtal, İstanbul, Türkiye. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Percutaneous Coronary Intervention, Drug-Eluting Stents, Myocardial Infarction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Drug‐eluting stents (DES) have revolutionized percutaneous coronary intervention (PCI) by improving event‐free survival compared to older stent designs. However, early‐generation DES with polymer matrixes have raised concerns regarding late stent thrombosis due to delayed vascular healing. To address these issues, biologically bioabsorbable polymer drug‐eluting stents (BP‐DES) and polymer‐free drug‐eluting stents (PF‐DES) have been developed.

Aim

The aim of the present study is to evaluate and compare the long‐term effects of different stent platforms in patients with acute coronary syndrome (ACS) undergoing PCI. Material and Methods We conducted a retrospective, observational study involving 1192 ACS patients who underwent urgent PCI. Patients were treated with thin‐ strut DP‐DES, ultra‐thin strut BP‐DES, or thin‐strut PF‐DES. The primary endpoint was a composite of cardiac death, target vessel myocardial infarction (TVMI), and clinically driven target lesion revascularization (CITLR) at 12 months and 4 years.

Results

The baseline demographics and clinical characteristics of patients in the three stent subgroups were similar. No significant differences were observed in target lesion failure (TLF), cardiac mortality, TVMI, and stent thrombosis (ST) rates among the three subgroups at both 12 months and 4 years. However, beyond the first year, the rate of CITLR was significantly lower in the ultra‐thin strut BP‐DES subgroup compared to thin‐strut DP‐DES, suggesting potential long‐term advantages of ultra‐thin strut BP‐DES. Additionally, both ultra‐thin strut BP‐DES and thin‐strut PF‐DES demonstrated lower ST rates after the first year compared to thin‐strut DP‐DES.

Conclusion

Our study highlights the potential advantages of ultra‐thin strut BP‐DES in reducing CITLR rates in the long term, and both ultra‐thin strut BP‐DES and thin‐strut PF‐DES demonstrate lower rates of ST beyond the first year compared to thin‐strut DP‐DES. However, no significant differences were observed in overall TLF, cardiac mortality and TVMI rates among the three stent subgroups at both 12 months and 4 years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Coronary SyndromePercutaneous Coronary InterventionDrug-Eluting StentsMyocardial InfarctionThrombosisHumansSirolimusPolymersRetrospective StudiesTreatment OutcomeStentsAbsorbable ImplantsProsthesis Design

Stichwörter der Autor:innen

acute coronary syndrome (ACS)drug-eluting stents (DES)percutaneous coronary intervention (PCI)

Substanzen

SirolimusPolymers

Autor:innen und Institutionen

  • Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Educatıon Research Hospıtal, İstanbul, Türkiye.
  • Department of Cardiology, Okan University Faculty of Medicine, İstanbul, Türkiye.
  • Department of Cardiology, Recep Tayyip Erdoğan University, Rize, Türkiye.
  • Department of Cardiology, Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital, İstanbul, Türkiye.

ORCID-Profile: Barış Yaylak, Fuat Polat, Tolga Onuk, Şükrü Akyüz, Ali Nazmi Çalık, Mustafa Çetin, Semih Eren, Feyza Mollaalioğlu, Zeynep Kolak, Furkan Durak, Şennur Ünal Dayı

Zitieren

APA

Yaylak, B., Polat, F., Onuk, T., Akyüz, Ş., Çalık, A. N., Çetin, M., Eren, S., Mollaalioğlu, F., Kolak, Z., Durak, F., & Dayı, Ş. Ü. (2023). The relation of polymer structure of stent used in patients with acute coronary syndrome revascularized by stent implantation with long‐term cardiovascular events. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.30881

Vancouver

Yaylak B, Polat F, Onuk T, Akyüz Ş, Çalık AN, Çetin M, et al. The relation of polymer structure of stent used in patients with acute coronary syndrome revascularized by stent implantation with long‐term cardiovascular events. Catheterization and Cardiovascular Interventions. 2023. doi:10.1002/ccd.30881

BibTeX
@article{Yaylak2023,
  author = {Yaylak, Barış and Polat, Fuat and Onuk, Tolga and Akyüz, Şükrü and Çalık, Ali Nazmi and Çetin, Mustafa and Eren, Semih and Mollaalioğlu, Feyza and Kolak, Zeynep and Durak, Furkan and Dayı, Şennur Ünal},
  title = {The relation of polymer structure of stent used in patients with acute coronary syndrome revascularized by stent implantation with long‐term cardiovascular events},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2023},
  doi = {10.1002/ccd.30881}
}
Kostenlos starten →